Journal article
Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective
Abstract
Allogeneic peripheral blood progenitor cell (PBPC) transplants are an alternative to BMT, although G-CSF mobilization dose, timing of pheresis and risk of GVHD are not well defined. We compared harvest characteristics, donor and recipient outcomes and costs of two PBPC transplant strategies with historical controls who received BMT. Twenty donors mobilized with four daily s.c. G-CSF doses (5 μg/kg/day) (group 1) and 20 mobilized with …
Authors
Couban S; Dranitsaris G; Andreou P; Price S; Tinker L; Foley R; Walker I; Jamal S; Jamal N; Spaner D
Journal
Bone Marrow Transplantation, Vol. 22, No. 12, pp. 1199–1205
Publisher
Springer Nature
Publication Date
December 1, 1998
DOI
10.1038/sj.bmt.1701504
ISSN
0268-3369